Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reboxetine Treatment in Depressed Children and Adolescents
NCT00426946Phase 4Unknown
- Sponsor
- Geha Mental Health Center
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of reboxetine in major depressive disorder (MDD), persistent depressive disorder (PDD), sponsored by Geha Mental Health Center. Status: unknown.
02
Drugs
reboxetine
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00426946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426946.